N
Neurogene Inc.
NGNE · NASDAQ · Healthcare · 571M
Closing price
$26.40
-0.38% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.1×
Enterprise value / EBITDAEV/EBITDA
-5.3×
Free cash flow yieldFCF yield
-14.0%
Return on equityROE
-34.1%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.1×
Interest coverage
-20641.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.